The first Bio-Rad Laboratories trade was made in Q2 2013.
Since then Jim Simons bought shares eighteen more times and sold shares on 23 occasions. The investor completely sold their stake between Q1 2023 and Q3 2023.
Avg closing price
Price range
Sold -1.1 Thousand shares
Q3 2023
Avg closing price
$385.83
Price range
$350.25
-
$422.63
Sold 97.1% shares (-37.1 Thousand shares)
Q2 2023
Avg closing price
$406.95
Price range
$359.49
-
$486.40
Sold 62.6% shares (-63.9 Thousand shares)
Q1 2023
Avg closing price
$468.12
Price range
$418.68
-
$503.00
Increased shares by 62.9% (+39.4 Thousand shares)
Q4 2022
Avg closing price
$403.63
Price range
$351.71
-
$456.01
Sold 59.4% shares (-91.8 Thousand shares)
Q3 2022
Avg closing price
$498.57
Price range
$412.59
-
$563.26
Sold 17.7% shares (-33.3 Thousand shares)
Q2 2022
Avg closing price
$520.81
Price range
$463.67
-
$597.16
Increased shares by 234.2% (+132 Thousand shares)
Q1 2022
Avg closing price
$602.81
Price range
$524.57
-
$735.42
Increased shares by 41.9% (+16.6 Thousand shares)
Q4 2021
Avg closing price
$748.36
Price range
$708.84
-
$794.68
Sold 15.6% shares (-7.3 Thousand shares)
Q3 2021
Avg closing price
$749.10
Price range
$657.71
-
$825.77
Sold 8.6% shares (-4.4 Thousand shares)
Q2 2021
Avg closing price
$608.62
Price range
$576.64
-
$649.04
New holding (+51.3 Thousand shares)
Q1 2021
Avg closing price
$592.18
Price range
$547.01
-
$662.35
Sold -47.4 Thousand shares
Q4 2020
Avg closing price
$569.50
Price range
$510.68
-
$643.45
Increased shares by 49.1% (+15.6 Thousand shares)
Q3 2020
Avg closing price
$506.50
Price range
$454.43
-
$535.60
Sold 48.5% shares (-29.9 Thousand shares)
Q2 2020
Avg closing price
$441.30
Price range
$334.87
-
$493.06
Sold 21.3% shares (-16.7 Thousand shares)
Q1 2020
Avg closing price
$367.68
Price range
$320.01
-
$409.07
Increased shares by 47.1% (+25.1 Thousand shares)
Q4 2019
Avg closing price
$352.55
Price range
$319.73
-
$374.20
Sold 59.6% shares (-78.6 Thousand shares)
Q3 2019
Avg closing price
$326.21
Price range
$304.55
-
$345.24
Sold 15.9% shares (-24.9 Thousand shares)
Q2 2019
Avg closing price
$299.43
Price range
$286.93
-
$312.59
Increased shares by 143.9% (+92.5 Thousand shares)
Q1 2019